High Dose AMBISOME on a Fluconazole Backbone for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: A Phase 3 Randomised Controlled Non-Inferiority Trial

Project: Research project

Description

High Dose AMBISOME on a Fluconazole Backbone for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: A Phase 3 Randomised Controlled Non-Inferiority Trial
StatusFinished
Effective start/end date5/1/184/30/19

Funding

  • INFECTIOUS DISEASES INSTITUTE

Fingerprint

Cryptococcal Meningitis
Fluconazole
Africa South of the Sahara
Therapeutics
Non-Randomized Controlled Trials